MRC is pleased to announce a new Experimental Medicine Panel, which will meet regularly to enhance the MRC’s current translational offering.
The Panel will support ambitious, academically-led applications of varying sizes focused on hypothesis-led interventional human studies. Through this new funding call, with an annual budget of >£10 million, the Experimental Medicine Panel will provide the dedicated and sustained support needed to drive our understanding of disease pathogenesis and enable the development of new targeted treatments.
